4d Molecular Therapeutics, Inc. · NASDAQ:FDMT
Novo Holdings A/S reported a 6.40% stake in 4d Molecular Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Novo Holdings A/S reported a 6.40% stake in 4d Molecular Therapeutics, Inc., 3,650,737 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 6.40%
- Shares
- 3,650,737
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Novo Holdings A/S | 6.40% | 3,650,737 |
Source
Related
- 4d Molecular Therapeutics, Inc.
- Novo Holdings A/S
- 4d Molecular Therapeutics, Inc. shareholders
- Schedule 13G · Novo Holdings A/S · Oct 20, 2025
- Form 4 · Bizily Scott · Oct 20, 2026
- Form 4 · Kirn David · Oct 7, 2026
- Form 4 · Bizily Scott · Sep 22, 2026
- Form 4 · Kirn David · Sep 16, 2026
- Form 4 · Bizily Scott · Sep 3, 2026